These pathways include mitogen-activated protein kinase 1 (MAPK1), which inhibits apoptosis and promotes cancer cell proliferation [158], or small mothers against decapentaplegic homolog 3 (SMAD3) required in the epithelial-mesenchymal transition (EMT) process [159]. This evidence concerns the gene MAPK1 and cancer.